1,041 material Form 8-K filings that 824 companies we cover made with the SEC in November 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
EPAM Systems reported third-quarter 2025 revenue of $1.394 billion, up 19.4% from a year earlier, while GAAP diluted EPS fell 19.4% to $1.91 and non-GAAP diluted EPS fell 1.3% to $3.08. The company raised its full-year 2025 revenue outlook to $5.430 billion to $5.445 billion and its full-year EPS outlook, and expects fourth-quarter revenue of $1.380 billion to $1.395 billion. Shareholders also received an update on capital returns, including $82.1 million of buybacks in the quarter and a new $1.0 billion repurchase program approved October 16, 2025.
Q3 2025 revenue of $1.394 billion, up 19.4% year over year; organic constant currency growth was 7.1%
Q3 GAAP diluted EPS of $1.91, down $0.46 or 19.4%; non-GAAP diluted EPS of $3.08, down $0.04 or 1.3%
Full-year 2025 revenue outlook raised to $5.430 billion to $5.445 billion; GAAP diluted EPS outlook $6.75 to $6.83, non-GAAP $11.36 to $11.44
Repurchased $82.1 million of stock in Q3; board approved a new repurchase program of up to $1.0 billion on October 16, 2025
Talos Energy reported a third-quarter 2025 net loss of $95.9 million, or $0.55 per diluted share, which includes a $60.2 million non-cash impairment, on total revenues of $450.1 million. The company also raised its full-year 2025 average daily production guidance to 94.0 to 97.0 MBoe/d and lowered its cash operating expense and capital expenditure ranges.
Q3 2025 net loss of $95.9 million ($0.55 per diluted share); adjusted net loss of $33.0 million ($0.19 per share)
Full-year 2025 production guidance raised to 94.0-97.0 MBoe/d from 91.0-95.0 MBoe/d
Full-year 2025 capital expenditure guidance lowered to $480-520 million from $490-530 million
Repurchased about 5.0 million shares for $48.1 million in Q3; $332.7 million cash at September 30, 2025
LifeStance reported third-quarter 2025 results on November 6, 2025, with revenue of $363.8 million, up 16% from a year earlier, and net income of $1.1 million compared with a net loss of $6.0 million in the prior-year quarter. The company raised its full-year 2025 Adjusted EBITDA guidance to $146 million to $152 million and raised the midpoint of its Center Margin expectations, while reiterating its full-year revenue outlook of $1.41 billion to $1.43 billion.
Q3 2025 revenue of $363.8 million, up 16%; clinician base rose 11% to 7,996.
Net income of $1.1 million versus a $6.0 million net loss a year earlier; Adjusted EBITDA of $40.2 million, up 31%.
Full-year 2025 Adjusted EBITDA guidance raised to $146 million to $152 million; revenue guidance reiterated at $1.41 billion to $1.43 billion.
Fourth-quarter 2025 outlook: total revenue of $368 million to $388 million and Adjusted EBITDA of $37 million to $43 million.
Dorian LPG reported results for the quarter ended September 30, 2025, with revenues of $124.1 million, up 50.5% from a year earlier, and net income of $55.4 million, or $1.30 per diluted share, compared with $9.4 million, or $0.22, a year earlier. The board also declared an irregular cash dividend of $0.65 per share, about $27.8 million in total, which the company says is not a recurring payment.
Revenues of $124.1 million for the quarter, up $41.7 million, or 50.5%, from $82.4 million
Net income of $55.4 million, or $1.30 per diluted share, versus $9.4 million, or $0.22, in the prior-year quarter
Irregular dividend of $0.65 per share, about $27.8 million, payable on or about December 2, 2025 to holders of record on November 17, 2025
Time charter equivalent rate per available day rose to $53,725 from $37,010, a 45.2% increase
Ralliant reported third-quarter 2025 revenue of $529 million, flat year-over-year and up 5% sequentially, while net earnings were $40 million, down from $91 million a year earlier. The company issued fourth-quarter revenue guidance of $535 million to $550 million and adjusted EPS guidance of $0.62 to $0.68, and declared a $0.05 quarterly dividend.
Net earnings of $40 million, or $0.35 per diluted share, versus $91 million, or $0.81 per diluted share, a year earlier; adjusted EPS was $0.60.
Test & Measurement revenue fell 14% to $203 million and posted a $2 million operating loss; Sensors & Safety Systems revenue rose 11% to $326 million.
Fourth-quarter 2025 outlook: revenue of $535 million to $550 million and adjusted EPS of $0.62 to $0.68.
Board declared a $0.05 per share dividend on October 30, 2025, payable December 23, 2025; a $200 million share repurchase authorization was approved June 28, 2025.
Ellington Financial reported third-quarter 2025 results on November 5, 2025. GAAP net income attributable to common stockholders was $0.29 per share, down from $0.45 in the prior quarter, while Adjusted Distributable Earnings were $0.53 per share. Net interest income rose to $49.7 million from $43.3 million, and the company priced $400 million of five-year senior unsecured notes, which shifts more of its borrowing to longer-term financing.
Net income attributable to common stockholders was $29.5 million, or $0.29 per share, for the quarter ended September 30, 2025, compared with $42.9 million, or $0.45 per share, for the quarter ended June 30, 2025.
Adjusted Distributable Earnings were $54.2 million, or $0.53 per share, including $16.1 million, or $0.16 per share, from Longbridge.
Book value per common share was $13.40 as of September 30, 2025, including the effects of $0.39 per share in dividends for the quarter.
Recourse debt-to-equity ratio was 1.8:1 as of September 30, 2025; $400 million of senior unsecured notes priced at a 7.375% yield and closed after quarter end.
APA Corporation reported third-quarter 2025 results on November 5, 2025. Net income attributable to common stock was $205 million, or $0.57 per diluted share, compared with a loss of $223 million a year earlier, while adjusted earnings were $332 million, or $0.93 per share, down from $370 million, or $1.00. Total revenues fell to $2.1 billion from $2.5 billion, but the company raised its fourth-quarter U.S. oil production guidance and expects $350 million in run-rate cost savings by year-end 2025.
Total revenues were $2,115 million in the third quarter of 2025, versus $2,531 million in the same quarter of 2024.
Adjusted earnings were $332 million ($0.93 per diluted share), versus $370 million ($1.00 per share) a year earlier.
Net debt was reduced by approximately $430 million in the quarter to roughly $4.0 billion, and free cash flow was $339 million.
U.S. oil production guidance for the fourth quarter was raised to 123,000 barrels per day, and run-rate savings are expected to reach $350 million by year-end 2025.
CF Industries reported third-quarter 2025 results, with net sales of $1,659 million versus $1,370 million a year earlier and net earnings attributable to common stockholders of $353 million versus $276 million. The company said the increase was driven by higher average selling prices and sales volumes, partly offset by higher natural gas costs, and it completed a $3 billion share repurchase authorization in October 2025.
Q3 2025 net sales $1,659 million vs $1,370 million in Q3 2024; net earnings per diluted share $2.19 vs $1.55
Q3 2025 adjusted EBITDA $667 million vs $511 million; 9M 2025 adjusted EBITDA $2.1 billion, up 20% from 9M 2024
Natural gas costs in cost of sales rose to $2.96 per MMBtu in Q3 2025 from $2.09 in Q3 2024
Completed $3 billion share repurchase authorization in October 2025; commenced a $2 billion authorization expiring December 2029
Centrus Energy reported third quarter 2025 results with net income of $3.9 million, or $0.19 per diluted share, compared with a net loss of $5.0 million a year earlier. Revenue rose 30% to $74.9 million, but the company posted a gross loss of $4.3 million and an operating loss of $16.6 million, and the profit was supported by a $12.9 million investment income line and an $11.9 million income tax benefit.
Total revenue of $74.9 million, up from $57.7 million in Q3 2024; LEU segment revenue was $44.8 million and Technical Solutions revenue was $30.1 million
Gross loss of $4.3 million, compared with gross profit of $8.9 million in Q3 2024; LEU segment gross loss of $7.8 million
Cash and cash equivalents of $1,631.8 million at September 30, 2025, after the $805.0 million 0% convertible senior notes issued August 18, 2025
Backlog of $3.9 billion as of September 30, 2025, extending to 2040
Murphy Oil reported a third-quarter 2025 net loss attributable to Murphy of $3.0 million, or $0.02 per diluted share, compared with net income of $139.1 million, or $0.93 per share, a year earlier. Revenue from production fell to $721.0 million from $753.2 million, and adjusted net income was $58.1 million, or $0.41 per diluted share, down from $110.7 million, or $0.74, in the prior-year quarter. The company reaffirmed its full-year 2025 production and capital expenditure guidance.
Q3 2025 net loss attributable to Murphy of $3.0 million, or $0.02 per diluted share, versus net income of $139.1 million, or $0.93 per share, in Q3 2024
Adjusted net income of $58.1 million, or $0.41 per diluted share, versus $110.7 million, or $0.74, a year earlier
Pretax impairment of $115 million ($92 million excluding noncontrolling interest) on the Dalmatian asset in the Gulf of America
Production of 200,383 BOEPD in the quarter; the company reaffirmed full-year 2025 production and capital expenditure guidance
CF Industries reported third-quarter 2025 net earnings attributable to common stockholders of $353 million, or $2.19 per diluted share, up from $276 million, or $1.55 per share, a year earlier. Net sales rose to $1.66 billion from $1.37 billion, and the company said higher average selling prices drove the gain. The company also completed its $3 billion 2022 buyback program in October and began a $2 billion program authorized in 2025.
Q3 2025 net earnings $353 million ($2.19 per diluted share) vs. $276 million ($1.55) in Q3 2024
Q3 2025 net sales $1.66 billion vs. $1.37 billion; adjusted EBITDA $667 million vs. $511 million
Nine-month 2025 net earnings $1.05 billion ($6.39 per share) vs. $890 million ($4.86) in 2024
Completed $3 billion buyback in October 2025 and commenced a $2 billion program, effective through December 2029
Black Hills Corp. reported third-quarter 2025 revenue of $430.2 million, up from $401.6 million a year earlier, and adjusted EPS of $0.45 versus $0.35. GAAP EPS was $0.34 versus $0.35, reflecting $0.10 per share of merger-related costs tied to the proposed NorthWestern Energy merger. The company reaffirmed its 2025 adjusted EPS guidance of $4.00 to $4.20 per share.
Q3 2025 revenue was $430.2 million versus $401.6 million in Q3 2024.
Q3 adjusted EPS was $0.45 versus $0.35; GAAP EPS was $0.34 versus $0.35.
Merger-related costs were $0.10 per share in Q3 and $0.11 per share year to date.
2025 adjusted EPS guidance of $4.00 to $4.20 was reaffirmed, the same as the prior GAAP guidance.
STERIS reported fiscal 2026 second-quarter results for the quarter ended September 30, 2025, with revenue from continuing operations up 10% to $1.5 billion and diluted EPS from continuing operations rising to $1.94 from $1.51 a year earlier. The company raised its fiscal 2026 adjusted EPS outlook to $10.15 to $10.30 and its free cash flow expectation to about $850 million, which points to higher expected per-share earnings and cash generation for shareholders.
Q2 revenue from continuing operations rose to $1,460.3 million from $1,328.9 million; constant currency organic growth was 9%.
Diluted EPS from continuing operations was $1.94 vs. $1.51; adjusted EPS was $2.47 vs. $2.14.
Fiscal 2026 adjusted EPS outlook raised to $10.15 to $10.30 from $9.90 to $10.15; free cash flow expected at about $850 million vs. $820 million prior.
Tariffs are estimated to reduce pre-tax profit by about $45 million, unchanged from prior outlook.
Rayonier reported third quarter 2025 net income attributable to Rayonier of $43.2 million ($0.28 per share) on revenues of $177.5 million, up from $28.8 million ($0.19 per share) on $124.1 million a year earlier. The company now expects full-year Adjusted EBITDA at or above the higher end of its prior guidance range, though it expects Southern Timber to fall modestly below its range and Pacific Northwest Timber toward the lower end.
Q3 pro forma net income was $50.2 million ($0.32 per share) versus $11.1 million ($0.07) a year earlier; Adjusted EBITDA was $114.3 million versus $57.2 million.
Real Estate Adjusted EBITDA was $73.8 million, and the company expects full-year Real Estate Adjusted EBITDA to exceed the high end of its prior range.
Q4 outlook: net income attributable to Rayonier of $13 to $17 million, EPS of $0.08 to $0.11, and Adjusted EBITDA of $50 to $60 million.
Quarter-end cash balance was $919.6 million; the company repurchased 1,226,384 shares for $30.1 million and expects the PotlatchDeltic merger to close in late first quarter or early second quarter 2026.
Phibro Animal Health reported fiscal first-quarter results ended September 30, 2025, with net sales up 40% to $363.9 million and diluted earnings per share of $0.65, compared with $0.17 a year earlier. The company raised its fiscal 2026 adjusted EBITDA guidance to $230 million to $240 million and kept its net sales guidance at $1.43 billion to $1.48 billion.
Quarterly net sales of $363.9 million, up $103.5 million, or 40%, with Animal Health sales up 55% to $283.5 million
Diluted EPS of $0.65 versus $0.17, and adjusted diluted EPS of $0.73 versus $0.35
Fiscal 2026 adjusted EBITDA guidance raised to $230 million to $240 million; net sales guidance of $1.43 billion to $1.48 billion maintained
At the November 4, 2025 annual meeting, stockholders elected three Class III directors, approved executive pay on an advisory basis, and ratified PricewaterhouseCoopers LLP as auditor
Ameren reported third quarter 2025 GAAP net income of $640 million, or $2.35 per diluted share, up from $456 million, or $1.70, a year earlier. Adjusted diluted EPS was $2.17, compared with $1.87. The company raised its 2025 GAAP EPS guidance to $5.08 to $5.28 and set 2026 diluted EPS guidance at $5.25 to $5.45, though the quarter included a $48 million tax benefit that the company excluded from adjusted results.
Q3 2025 GAAP diluted EPS was $2.35 vs. $1.70 in Q3 2024; adjusted diluted EPS was $2.17 vs. $1.87.
Q3 2025 included a $48 million ($0.18 per share) tax benefit from a FERC order on net operating loss carryforwards, excluded from adjusted earnings.
2025 GAAP EPS guidance raised to $5.08 to $5.28 and adjusted EPS guidance to $4.90 to $5.10, both up from the original $4.85 to $5.05 range.
2026 diluted EPS guidance set at $5.25 to $5.45; analyst call scheduled for 9 a.m. Central Time on November 6, 2025.
Atmos Energy reported fiscal 2025 earnings of $7.46 per diluted share on net income of $1.2 billion and initiated fiscal 2026 EPS guidance of $8.15 to $8.35. The board also declared a quarterly dividend of $1.00 per share, an indicated annual dividend of $4.00 that the company says is a 14.9% increase over fiscal 2025.
Fiscal 2025 EPS of $7.46 on net income of $1.2 billion; capital expenditures were $3.6 billion, about 87% focused on safety and reliability
Fiscal 2026 EPS guidance of $8.15 to $8.35 per diluted share; capital expenditure guidance of approximately $4.2 billion
Quarterly dividend of $1.00 per share, an indicated annual dividend of $4.00, a 14.9% increase over fiscal 2025
Conference call to discuss results scheduled for Thursday, November 6, 2025, at 10:00 a.m. Eastern Time
Host Hotels & Resorts reported third quarter 2025 revenues of $1,331 million, up 0.9% from a year earlier, and GAAP net income of $163 million, up from $84 million, which the company said benefited from a gain on the sale of the Washington Marriott at Metro Center. Adjusted EBITDAre fell 3.3% to $319 million, and the company raised its full-year 2025 guidance, including net income of $780 million and diluted earnings per share of $1.11.
Q3 2025 revenues were $1,331 million, up 0.9%; diluted earnings per share were $0.23 versus $0.12 in Q3 2024.
Comparable hotel RevPAR rose 0.2% to $208.07; comparable hotel Total RevPAR rose 0.8% to $335.42.
Full-year 2025 guidance: comparable hotel RevPAR growth of about 3.0%, net income of $780 million, and Adjusted EBITDAre of $1,730 million, up from prior midpoints of $616 million and $1,705 million respectively.
Agreement with Marriott to spend $300 million to $350 million through 2029 on a second transformational capital program at four properties.
Hecla Mining reported record third quarter 2025 sales of $409.5 million, up 35% from the second quarter, and net income applicable to common stockholders of $100.6 million, or $0.15 per share, compared with $57.6 million in the prior quarter. The company repaid its revolving credit facility in full, reduced its net leverage ratio to 0.3x from 0.7x, and reported $90.1 million in free cash flow, while also announcing a common dividend of $0.00375 per share and a Series B preferred dividend of $0.875.
Sales of $409.5 million and net income of $100.6 million, or $0.15 per share, for the quarter ended September 30, 2025, both described by the company as records
Free cash flow of $90.1 million and cash of $133.9 million at quarter end; revolving credit facility fully repaid and net leverage ratio at 0.3x
Common dividend of $0.00375 per share, record date November 24, 2025, payable on or about December 8, 2025; Series B preferred dividend of $0.875, record date December 15, 2025, payable on or about January 2, 2026
2025 Greens Creek silver production guidance tightened to 8.4-8.8 million ounces; Lucky Friday total cost of sales guidance raised to $175 million from $165 million
Primerica reported third-quarter 2025 results with total revenues of $839.9 million, up 8% from a year earlier, and net income of $206.8 million, up 6% from continuing operations in the prior-year period. Investment and Savings Products sales reached $3.7 billion, the highest quarterly result in the company's history, but Term Life policies issued fell 15%, and recruits fell 29%, which bears on future sales capacity.
Diluted EPS was $6.35, up 11% from $5.72; diluted adjusted operating EPS was $6.33, up 11% from $5.68.
Investment and Savings Products sales rose 28% to $3.7 billion, and average client asset values rose 14% to $123.1 billion.
Term Life issued 79,379 new policies, down 15%, and recruits fell 29% to 101,156 compared with the prior-year period.
The company repurchased $129 million of common stock in the quarter and declared a $1.04 per share dividend payable December 15, 2025.
American States Water reported third-quarter 2025 diluted earnings per share of $1.06, up from $0.95 a year earlier, on total operating revenues of $182.7 million compared with $161.8 million. The company attributed the gain mainly to higher construction activity at its contracted services segment and new customer rates at its water and electric utilities, and its board approved a fourth-quarter dividend of $0.5040 per share.
Q3 2025 net income was $41.2 million, compared with $35.8 million in Q3 2024.
Nine-month 2025 diluted EPS was $2.63, compared with $2.42 for the same period in 2024.
Contracted services segment EPS rose to $0.19 from $0.11, and the company expects that segment to contribute $0.59 to $0.63 per share for full-year 2025.
Fourth-quarter dividend of $0.5040 per share is payable December 2, 2025, to shareholders of record on November 14, 2025.
MetLife reported third-quarter 2025 net income of $818 million, or $1.22 per share, down 36% from a year earlier, mainly due to higher net derivative losses and net investment losses. Adjusted earnings rose 15% to $1.6 billion, and adjusted earnings per share rose 22% to $2.37, driven by higher variable investment income and volume growth.
Net income was $818 million ($1.22 per share), down 36% from $1,275 million in the third quarter of 2024; net derivative losses were $929 million.
Adjusted earnings were $1,584 million, up 15%; adjusted earnings per share were $2.37, up 22%.
Premiums, fees and other revenues were $12.5 billion, flat compared with the prior-year quarter.
MetLife returned approximately $875 million to shareholders through share repurchases and common stock dividends, and held $4.9 billion in holding company cash and liquid assets at quarter end.
MKS Inc. reported third-quarter 2025 revenue of $988 million, up from $896 million a year earlier, with GAAP net income of $74 million, or $1.10 per diluted share, compared with $62 million, or $0.92, in the third quarter of 2024. The company guided fourth-quarter 2025 revenue to $990 million, plus or minus $40 million, and said it made a $100 million voluntary debt prepayment in October.
Q3 2025 total net revenues of $988 million, versus $896 million in Q3 2024 and $973 million in Q2 2025
GAAP net income of $74 million and $1.10 per diluted share; non-GAAP net earnings per diluted share of $1.93
Fourth-quarter 2025 guidance: revenue of $990 million plus or minus $40 million; non-GAAP EPS of $2.27 plus or minus $0.34
Net leverage ratio of 3.9x at September 30, 2025; additional $100 million voluntary prepayment in October 2025
Coty reported fiscal first-quarter results for the period ended September 30, 2025, with net revenue of $1,577.2 million, down 6% on a reported basis and 8% like-for-like. Reported operating income fell 22% to $185.0 million and reported EPS was $0.07, versus $0.09 a year earlier. The company said its prior outlook is unchanged, including a return to growth in the second half of fiscal 2026, which shareholders will need to see in later results.
Net revenue of $1,577.2 million, down 6% reported and 8% like-for-like; Consumer Beauty down 9% and Prestige down 4% on a reported basis
Reported operating income of $185.0 million versus $237.8 million; reported EPS of $0.07 versus $0.09
Adjusted EBITDA of $296.1 million, down 18%; Q2 like-for-like sales expected at the more favorable end of the prior decline range of 3% to 5%
Total debt of $4,069.3 million; retained 25.8% Wella stake valued at $1,003.0 million, which the company is pursuing to monetize
Watts Water Technologies reported third quarter 2025 net sales of $611.7 million, up 13% from a year earlier, with diluted EPS of $2.45, up 19%. The company raised its full-year 2025 sales and margin outlook and said it acquired Haws Corporation on November 4, 2025, which shareholders may weigh against higher-than-prior-year sales and profit.
Net sales of $611.7 million, up 13% on a reported basis and 9% organically; Europe organic sales fell 2%
Diluted EPS of $2.45 versus $2.06; adjusted diluted EPS of $2.50 versus $2.03
Full-year 2025 reported sales growth now expected at 7% to 8%; adjusted operating margin expected at 19.1% to 19.2%
Enact Holdings reported third-quarter 2025 net income of $163 million, or $1.10 per diluted share, down from $181 million, or $1.15 per share, a year earlier, and slightly below the second quarter's $168 million. The company raised its expected total 2025 capital return to approximately $500 million and declared a $0.21 quarterly dividend, while the loss ratio rose to 15% from 5% a year ago.
Net income was $163 million, or $1.10 per diluted share, versus $181 million, or $1.15, in Q3 2024
Adjusted operating income was $166 million, or $1.12 per diluted share, versus $182 million, or $1.16, in Q3 2024
Loss ratio was 15%, compared with 5% in Q3 2024 and 10% in Q2 2025
Expected total 2025 capital return raised to approximately $500 million; $0.21 dividend payable December 11, 2025
HubSpot reported third-quarter 2025 results on November 5, 2025, with total revenue of $809.5 million, up 21% from a year earlier, and GAAP net income of $16.5 million, compared with $8.1 million in the prior-year quarter. The company also issued fourth-quarter and full-year 2025 guidance, including full-year revenue of $3.113 billion to $3.115 billion. Separately, the board increased to 11 directors and appointed Clara Shih as a Class III director effective November 3, 2025.
Q3 2025 total revenue was $809.5 million, up 21% as reported and 18% in constant currency.
GAAP net income was $16.5 million, or $0.31 per diluted share, versus $8.1 million, or $0.16, in Q3 2024; non-GAAP diluted EPS was $2.66 versus $2.18.
Full-year 2025 guidance: revenue of $3.113 billion to $3.115 billion and non-GAAP diluted EPS of $9.60 to $9.62.
Clara Shih was appointed a Class III director effective November 3, 2025, with the board expanded to 11 members.
Genworth reported third-quarter 2025 net income available to common stockholders of $116 million, or $0.28 per diluted share, up from $51 million in the prior quarter and $85 million a year earlier. Adjusted operating income fell to $17 million, or $0.04 per diluted share, from $68 million in the prior quarter and $48 million a year earlier. The company also announced a new $350 million share repurchase authorization, and the GAAP result was helped by $78 million of net investment gains and a $34 million tax benefit.
Net income available to common stockholders was $116 million ($0.28 diluted), versus $51 million in Q2 2025 and $85 million in Q3 2024.
Adjusted operating income was $17 million ($0.04 diluted), versus $68 million in Q2 2025 and $48 million in Q3 2024.
Net income included a $34 million tax benefit and $78 million of net investment gains; Long-Term Care Insurance adjusted operating loss was $100 million.
Board authorized a new $350 million share repurchase program; $76 million was executed in the quarter.
Amcor reported first-quarter fiscal 2026 results for the three months ended September 30, 2025, its first full quarter combined with Berry Global, which was acquired April 30, 2025. Net sales were $5,745 million versus $3,353 million a year earlier, and adjusted EPS was 19.3 cents, while GAAP diluted EPS fell to 11.3 cents from 13.2 cents. The company reaffirmed its fiscal 2026 adjusted EPS guidance of 80 to 83 cents and free cash flow guidance of $1.8 billion to $1.9 billion, and raised its quarterly dividend to 13.0 cents per share.
Net sales of $5,745 million, up 71% reported and 68% in constant currency, including about $2.4 billion of acquired sales
Adjusted EPS of 19.3 cents, up 18% in constant currency; GAAP diluted EPS of 11.3 cents versus 13.2 cents a year earlier
Fiscal 2026 guidance reaffirmed: adjusted EPS of 80 to 83 cents and free cash flow of $1.8 billion to $1.9 billion
Quarterly dividend increased to 13.0 cents from 12.75 cents; record date November 28, 2025 and payment date December 17, 2025
Albemarle reported third-quarter 2025 net sales of $1.3 billion, down 3.5% from a year earlier, mainly on lower Energy Storage pricing. The company posted a net loss of $161 million, or $1.72 per diluted share, which includes a non-cash goodwill impairment charge tied to Ketjen, but adjusted EBITDA rose 7% to $226 million and management said full-year 2025 results are now expected toward the higher end of its $9/kg lithium price scenario ranges, which matters to shareholders because it signals a stronger expected year despite the charge.
Net sales were $1.3 billion, down 3.5% from $1.35 billion in the third quarter of 2024; Energy Storage pricing fell 16% while volumes rose 8%.
Net loss attributable to Albemarle was $161 million, or $1.72 per diluted share, including a $181 million goodwill impairment charge associated with Ketjen.
Adjusted EBITDA was $226 million, up 7%; adjusted loss was $0.19 per diluted share versus $1.55 a year earlier.
Full-year 2025 outlook was enhanced toward the higher end of the $9/kg scenario ranges, capital expenditures are now expected at about $600 million, and positive free cash flow of $300 million to $400 million is expected.
Global Net Lease reported third-quarter 2025 revenue of $121.0 million, down from $138.7 million a year earlier, mainly due to asset dispositions including the multi-tenant retail portfolio sale. It raised its full-year 2025 AFFO per share guidance to $0.95 to $0.97 from $0.92 to $0.96, and Fitch upgraded its corporate credit rating to investment-grade BBB-. For shareholders, lower revenue and AFFO per share were partly offset by a narrower net loss, the higher guidance range and a $2.0 billion reduction in net debt since third quarter 2024.
Q3 2025 revenue was $121.0 million versus $138.7 million in Q3 2024; AFFO was $53.2 million, or $0.24 per share, versus $73.9 million, or $0.32 per share
Net loss attributable to common stockholders narrowed to $71.1 million from $76.6 million a year earlier
Full-year 2025 AFFO per share guidance raised to $0.95 to $0.97 from $0.92 to $0.96; Net Debt to Adjusted EBITDA guidance unchanged at 6.5x to 7.1x
Fitch upgraded the corporate credit rating to investment-grade BBB- from BB+; company completed a $1.8 billion refinancing of its Revolving Credit Facility and repurchased 12.1 million shares for $91.7 million year-to-date through October 3
FICO reported fourth-quarter fiscal 2025 revenue of $516 million, up 14% from $454 million a year earlier, and diluted earnings per share of $6.42 versus $5.44. Growth came mainly from Scores revenue, which rose 25%, and the company issued fiscal 2026 guidance calling for revenue of $2.35 billion and GAAP EPS of $33.47. For shareholders, revenue and profit both grew, though a $10.9 million restructuring charge reduced reported results.
Quarterly net income was $155.0 million, or $6.42 per diluted share, versus $135.7 million, or $5.44, a year earlier.
Scores revenue was $311.6 million, up 25%; Software revenue was flat at $204.2 million.
Fiscal 2026 guidance: revenue $2.35 billion, GAAP net income $795 million, GAAP EPS $33.47, non-GAAP EPS $38.17.
A pre-tax restructuring charge of $10.9 million, or $0.34 per share after tax, was recorded in the quarter.
Devon Energy reported third-quarter 2025 net earnings of $687 million, or $1.09 per diluted share, down from $899 million in the second quarter and $812 million a year earlier, while total revenues rose to $4.3 billion. Production of 853,000 barrels of oil equivalent per day exceeded the top end of guidance, and the company gave fourth-quarter and 2026 production and capital outlooks, with 2026 capital projected at $3.5 billion to $3.7 billion.
Net earnings were $687 million, or $1.09 per diluted share; core earnings were $656 million, or $1.04 per diluted share.
Operating cash flow was $1.7 billion and free cash flow was $820 million.
Production averaged 853,000 Boe per day, above the top end of guidance; 2026 production is projected at 835,000 to 855,000 Boe per day.
The company declared a quarterly dividend of $0.24 per share, payable Dec. 30, 2025, and repurchased $250 million of shares in the quarter.
Deluxe reported third quarter 2025 revenue of $540.2 million, up 2.2% from a year earlier, and net income of $33.7 million, up from $8.9 million. The company raised its full-year 2025 adjusted diluted EPS guidance to $3.45 to $3.60 and kept its revenue, adjusted EBITDA, and free cash flow outlook within narrowed ranges.
Q3 2025 revenue was $540.2 million, up 2.2% from $528.4 million; comparable adjusted revenue rose 2.5%.
Q3 comparable adjusted diluted EPS was $1.09, up 29.8% from $0.84; GAAP diluted EPS was $0.74 versus $0.20.
Full-year 2025 adjusted diluted EPS guidance was raised to $3.45 to $3.60; revenue guidance of $2.11 to $2.13 billion was affirmed.
Free cash flow for the first nine months was $95.9 million, up $31.6 million; the board approved a $0.30 quarterly dividend payable December 1, 2025.
EnerSys reported fiscal second-quarter 2026 net sales of $951.3 million, up 7.7% from a year earlier and above its guidance range of $870 million to $910 million. GAAP diluted EPS fell to $1.80 from $2.01 because of $28.6 million in unfavorable highlighted items, while adjusted diluted EPS rose to $2.56 from $2.12. The company gave third-quarter guidance but kept full-year quantitative guidance paused, citing the macroeconomic environment.
Net sales of $951.3 million, up 7.7%, above the $870 million to $910 million guidance range
GAAP diluted EPS of $1.80 versus $2.01 a year earlier; adjusted diluted EPS of $2.56 versus guidance of $2.33 to $2.43
Third-quarter fiscal 2026 outlook: net sales of $920 million to $960 million and adjusted diluted EPS of $2.71 to $2.81; full-year quantitative guidance paused
Quarterly dividend of $0.2625 per share, payable December 26, 2025, to holders of record as of December 12, 2025
Innoviva reported third-quarter 2025 total revenue of $107.8 million, up 20% from a year earlier, and net income of $89.9 million, or $1.30 basic per share, compared with $1.2 million in the prior-year quarter. Income from operations fell 20% to $34.6 million, which the company attributed mainly to a non-recurring research and development expense, while net favorable changes in investment fair values drove the higher net income. The company also announced a new share repurchase program of up to $125 million.
Total revenue was $107.8 million, up 20% from $89.5 million in Q3 2024.
Net income was $89.9 million, or $1.30 basic per share, versus $1.2 million, or $0.02 per share, a year earlier.
Income from operations was $34.6 million, down 20% from $43.2 million, mainly due to a non-recurring R&D expense.
Board authorized a new share repurchase program of up to $125.0 million, with no termination date.
Texas Pacific Land reported third-quarter 2025 net income of $121.2 million, or $5.27 per diluted share, up from $116.1 million in the second quarter, on total revenues of $203.1 million. The board also approved a three-for-one stock split, expected in December 2025, which will change per-share figures once effective.
Q3 2025 total revenues were $203.1 million versus $187.5 million in Q2 2025; diluted EPS was $5.27 versus $5.05.
Water Services and Operations segment revenues were $80.8 million, a company record.
Three-for-one stock split approved November 3, 2025; expected to be completed in December 2025, subject to the Board setting the effective date.
Royalty acquisition of about 17,306 net acres closed November 3, 2025 for $474.1 million in cash; quarterly dividend of $1.60 per share payable December 15, 2025.
Allstate reported third-quarter 2025 results, with revenue of $17.3 billion, up 3.8% from the prior year quarter. Net income applicable to common shareholders was $3.7 billion, or $13.95 per diluted share, compared with $1.2 billion a year earlier, and adjusted net income was $3.0 billion, or $11.17 per diluted share, versus $3.91 a year earlier. Net income includes a $720 million gain on disposition of operations, which adjusted net income excludes.
Total revenues $17.3 billion, up $628 million or 3.8% from Q3 2024
Net income applicable to common shareholders $3.7 billion, or $13.95 per diluted share, versus $4.33 a year earlier
Adjusted net income $3.0 billion, or $11.17 per diluted share, versus $3.91 a year earlier
Property-Liability recorded combined ratio 80.1 versus 96.4; catastrophe losses $558 million versus $1.7 billion
Universal Corporation reported results for the quarter ended September 30, 2025, with sales up 6% to $754.2 million and operating income down 2% to $67.6 million. The company also added Gregory A. Trojan, a retired restaurant, retail and consumer products executive, to its board, expanding it to 10 members effective November 5, 2025.
Q2 sales and other operating revenue $754.2 million vs. $710.8 million a year earlier, up 6%
Q2 operating income $67.6 million vs. $68.7 million, down 2%; non-GAAP adjusted operating income down 15% from $79.3 million
Q2 diluted EPS $1.36 vs. $1.03; non-GAAP adjusted diluted EPS $1.36 vs. $1.45, down 6%
Gregory A. Trojan appointed director effective November 5, 2025; expected to join the Audit, Compensation and Human Resources, and Finance and Pension Investment committees
Pebblebrook Hotel Trust reported third-quarter 2025 results, showing a $32.4 million net loss compared with $45.1 million of net income a year earlier. Adjusted EBITDAre fell 11.6% to $99.2 million, and the company trimmed the midpoint of its 2025 Adjusted EBITDAre outlook by $3.0 million, while the Adjusted FFO per diluted share midpoint was unchanged.
Q3 net loss of $32.4 million, versus net income of $45.1 million in Q3 2024; the quarter included a $46.5 million impairment charge
Q3 Adjusted EBITDAre of $99.2 million, down from $112.2 million; Adjusted FFO per diluted share of $0.51, down from $0.59
Total revenues of $398.7 million, down from $404.5 million a year earlier
2025 outlook: Adjusted EBITDAre of $332.5 million to $341.5 million, midpoint reduced by $3.0 million; Adjusted FFO per diluted share of $1.50 to $1.57, midpoint unchanged
e.l.f. Beauty reported second-quarter fiscal 2026 results for the three months ended September 30, 2025, with net sales up 14% to $343.9 million but GAAP net income down to $3.0 million from $19.0 million a year earlier. The company also issued fiscal 2026 guidance calling for net sales of $1,550 million to $1,570 million and adjusted diluted EPS of $2.80 to $2.85, compared with fiscal 2025 adjusted EPS of $3.39.
Q2 net sales rose 14% to $343.9 million; gross margin fell about 165 basis points to 69%, mainly due to higher tariff costs
GAAP diluted EPS was $0.05 versus $0.33 a year earlier; adjusted diluted EPS was $0.68 versus $0.77
Adjusted EBITDA was $66.2 million, down 4% year over year
Fiscal 2026 outlook: adjusted net income of $165 million to $168 million, versus $198 million in fiscal 2025
Corpay reported third-quarter 2025 revenue of $1,172.5 million, up 14%, with GAAP diluted EPS of $3.91 versus $3.90 a year earlier, and raised its full-year 2025 outlook. The company also completed the Alpha Group acquisition on October 31, 2025, for about £1.8 billion in cash, funded by borrowings under an amended credit facility that adds a $900 million Term Loan B.
Q3 2025 revenue was $1,172.5 million, up from $1,029.2 million; net income attributable to Corpay was $277.9 million, versus $276.4 million.
Adjusted net income per diluted share rose 14% to $5.70 from $5.00.
Full-year 2025 revenue guidance was raised to $4,505 million to $4,525 million, and GAAP diluted EPS guidance to $15.88 to $16.08.
The Alpha acquisition closed October 31, 2025; on November 5, 2025, Revolver B commitments rose $1 billion to $1.5 billion and a $900 million Term Loan B maturing November 5, 2032 was added.
Third-quarter oil and gas sales rose to $1.32 billion from $1.22 billion a year earlier, but net income attributable to Class A shareholders fell to $59.2 million, or $0.08 per diluted share, from $386.4 million, or $0.53. The filing also shows a $264.3 million loss on extinguishment of debt, compared with $5.1 million a year earlier. The company raised its midpoint 2025 production guidance and said no other guidance ranges changed.
Oil and gas sales were $1.32 billion for the quarter ended September 30, 2025, versus $1.22 billion a year earlier.
Net income attributable to Class A Common Stock was $59.2 million ($0.08 diluted), versus $386.4 million ($0.53) in the third quarter of 2024.
Loss on extinguishment of debt was $264.3 million, versus $5.1 million a year earlier.
Midpoint 2025 guidance raised to 181.5 MBbls/d for oil and 394.0 MBoe/d for total production; fourth quarter base dividend declared at $0.15 per share, payable December 31, 2025.
Veeco reported third quarter 2025 revenue of $165.9 million and GAAP net income of $10.6 million, or $0.17 per diluted share, both down from the year-earlier quarter. The company guided fourth quarter 2025 revenue to $155 million to $175 million, while the pending merger with Axcelis Technologies continues.
Q3 2025 revenue $165.9 million vs $184.8 million in Q3 2024
Q3 2025 GAAP net income $10.6 million ($0.17 per diluted share) vs $22.0 million ($0.36)
Q3 2025 non-GAAP net income $21.8 million ($0.36 per diluted share) vs $28.3 million ($0.46)
Q4 2025 guidance: revenue $155 million to $175 million; GAAP EPS ($0.07) to $0.05
CONMED reported third quarter 2025 sales of $337.9 million, up 6.7% year over year, while GAAP diluted EPS fell to $0.09 from $1.57 a year earlier, after product rationalization costs and other charges. The company also raised the midpoint of its adjusted EPS guidance, authorized a $150.0 million share repurchase program, and suspended its quarterly cash dividend, which matters to shareholders because it changes how cash is returned to them.
Q3 2025 sales were $337.9 million, up 6.7% as reported and 6.3% in constant currency.
GAAP diluted EPS was $0.09 versus $1.57 in Q3 2024; adjusted diluted EPS was $1.08 versus $1.05.
Full-year 2025 adjusted diluted EPS guidance is $4.48 to $4.53, compared with the prior $4.40 to $4.55.
Board authorized a $150.0 million buyback effective October 31, 2025 and suspended the quarterly dividend; at least $25.0 million in annual repurchases is expected from 2026.
LiveRamp reported results for the quarter ended September 30, 2025, with total revenue up 8% to $200 million and GAAP diluted earnings per share of $0.42, compared with $0.03 a year earlier. The company also issued an updated fiscal 2026 outlook, with full-year revenue now expected at $804 million to $818 million and non-GAAP operating income at $178 million to $182 million.
Q2 total revenue $200 million, up 8%; subscription revenue $150 million, up 5%; Marketplace & Other revenue $50 million, up 18%
GAAP income from operations $21 million versus $7 million a year earlier; non-GAAP operating income $45 million, up 10%
GAAP diluted EPS $0.42 versus $0.03; non-GAAP diluted EPS $0.55 versus $0.51
Q3 fiscal 2026 revenue guidance of $209 million to $213 million; ARR $516 million, up 7%
SiTime reported third-quarter 2025 revenue of $83.6 million, up 45% from $57.7 million a year earlier. GAAP net loss was $8.0 million, or $0.31 per diluted share, compared with a $19.3 million loss in the year-ago quarter, while non-GAAP net income was $23.4 million, or $0.87 per diluted share. CEO Rajesh Vashist said he expects growth to exceed 50% year over year for 2025.
Q3 2025 net revenue was $83.6 million, up from $57.7 million in Q3 2024.
GAAP net loss was $8.0 million, or $0.31 per diluted share, versus a $19.3 million loss in Q3 2024.
Non-GAAP net income was $23.4 million, or $0.87 per diluted share; cash, cash equivalents and short-term investments were $809.6 million at September 30, 2025.
CEO Rajesh Vashist expects growth to exceed 50% year over year for 2025; the company will discuss its business outlook on the earnings call.
Acadia Pharmaceuticals reported third quarter 2025 total revenue of $278.6 million, up 11% from a year earlier, and net income of $71.8 million, or $0.42 per diluted share, compared with $32.8 million a year earlier. The company raised its 2025 NUPLAZID net product sales guidance and lowered the top of its DAYBUE sales range while narrowing it; the net income gain includes a one-time tax benefit.
Q3 2025 total revenue of $278.6 million, up 11% year-over-year; NUPLAZID sales $177.5 million and DAYBUE sales $101.1 million
Q3 net income of $71.8 million ($0.42 diluted) vs. $32.8 million ($0.20) in Q3 2024, including a one-time tax benefit tied to the One Big Beautiful Bill Act
2025 total revenue guidance of $1.070 to $1.095 billion, vs. prior $1.045 to $1.095 billion; NUPLAZID guidance raised to $685 to $695 million from $665 to $690 million
Cash, cash equivalents and investment securities of $847.0 million at September 30, 2025
NCR Atleos reported third quarter 2025 results, with total revenue up 4% to $1.12 billion and net income attributable to Atleos up 24% to $26 million. The company reaffirmed its full-year 2025 guidance ranges, and it is revising previously issued financial statements for immaterial misstatements that overstated pre-tax income in fiscal years 2023 and 2024 and the first two quarters of 2025.
Total revenue $1.12 billion, up 4% year over year; recurring revenue was 70% of total revenue
Net income attributable to Atleos $26 million, up 24%; GAAP diluted EPS $0.34, up 21%; adjusted diluted EPS $1.09, up 22%
Net cash provided by operating activities $27 million in the quarter, compared with $107 million in the prior year period
Full-year 2025 guidance ranges reaffirmed; conference call scheduled for November 6, 2025 at 8:30 a.m. Eastern Time
Vir Biotechnology reported third quarter 2025 results for the period ended September 30, 2025. Net loss narrowed to $163.1 million, or $1.17 per share, from $213.7 million, or $1.56 per share, a year earlier, mainly because license expenses were lower than in the prior-year quarter, but total revenues fell to $0.2 million from $2.4 million. The company said it had $810.7 million in cash, cash equivalents and investments and expects that to fund operations into mid-2027.
Net loss was $163.1 million, or $1.17 per share, versus $213.7 million, or $1.56 per share, in Q3 2024
Total revenues were $0.2 million versus $2.4 million in Q3 2024; R&D expenses were $151.5 million versus $195.2 million
Cash, cash equivalents and investments were $810.7 million at September 30, 2025, down about $81.4 million in the quarter; ECLIPSE 1 Phase 3 enrollment completed about two months early
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.